1998
Financial Statements
| The following information is excerpted from Noven's 1998 Annual Report to Shareholders. |
|
Back
Notes
to Financial Statements
Years
Ended December 31, 1998, 1997 and 1996
Unaudited Quarterly Condensed Financial
Data
| 1998 |
First
|
Second
|
Third
|
Fourth
|
Full
Year
|
 |
|||||
| (in thousands, except per share amounts) | |||||
|
Revenue |
$
2,548
|
$
6,395
|
$5,018
|
$
7,881
|
$
21,842
|
| Total operating expenses |
6,014
|
8,038
|
4,965
|
7,343
|
26,360
|
| Income (loss) from operations |
(3,466)
|
(1,643)
|
53
|
538
|
(4,518)
|
| Interest income |
190
|
86
|
86
|
77
|
439
|
| Net income (loss) |
$(3,276)
|
$(1,557)
|
$
139
|
$
615
|
$
(4,079)
|
| Net income (loss) per share |
$ (0.16)
|
$ (0.08)
|
$ 0.01
|
$
0.03
|
$
(0.19)
|
|
1997 |
First
|
Second
|
Third
|
Fourth
|
Full
Year
|
|
|||||
| Revenue |
$
1,429
|
$
3,975
|
$5,720
|
$
3,143
|
$
14,267
|
| Total operating expenses |
4,441
|
6,193
|
5,981
|
8,133
|
24,748
|
| Loss from operations |
(3,012)
|
(2,218)
|
(261)
|
$(4,990)
|
(10,481)
|
| Interest and other income |
252
|
189
|
257
|
226
|
924
|
| Net loss |
$(2,760)
|
$(2,029)
|
$ (4)
|
$(4,764)
|
$ (9,557)
|
| Net loss per share |
$ (0.14)
|
$
(0.10)
|
$ 0.00
|
$ (0.23)
|
$ (0.47)
|
Copyright © 1999 Noven Pharmaceuticals, Inc. All rights reserved.